Modalis Therapeutics Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was JPY 532 million. Basic loss per share from continuing operations was JPY 17.86.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77 JPY | 0.00% | -1.28% | -37.90% |
Apr. 15 | Modalis Therapeutics to See Reduced Expenses of 250 to 350 Million After Cutting Jobs | MT |
Feb. 23 | Modalis Therapeutics to Reduce Stated Capital and Capital Reserves | MT |
1st Jan change | Capi. | |
---|---|---|
-37.90% | 16.73M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.87% | 22.15B | |
-17.37% | 21.02B | |
-7.98% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4883 Stock
- News Modalis Therapeutics Corporation
- Modalis Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023